The allostatic load framework postulates that an important pathway connecting the social environment with health involves biological responses to stressful stimuli and the subsequent dysregulation of interrelated physiological systems. We formulate a new measure for cumulative physiological dysregulation using a grade of membership model estimated with biodemographic data from a national sample of older Taiwanese persons. We investigate associations between the measure and physical, psychological, and cognitive function. The results provide insights into the relationships between a set of biological profi les and various health outcomes, identify limitations of earlier approaches, and underscore next steps in the development of improved formulations of physiological dysregulation.
vast literature demonstrates a strong association between the social environment and health (Adler et al. 1999; Seeman and Crimmins 2001) ; more recent work has begun to focus on the biological mechanisms through which these two sets of factors are interrelated. The framework of allostatic load (McEwen 1998b; McEwen and Stellar 1993) describes how the accumulation of stressful life experiences may constitute an important pathway that links social factors to health. Allostatic load refl ects "the price the body pays for being forced to adapt to adverse psychological or physical situations" (McEwen 2002:924) and involves the neuroendocrine, sympathetic nervous, immune, and cardiovascular systems, as well as metabolic pathways. The deleterious effects of allostatic load, which include poor physical, psychological, and cognitive functioning, are believed to result from chronic exposure to physiological parameters outside "normal" operating ranges (McEwen 1998a) . From a demographer's perspective, physiological dysregulation can be viewed as an early indicator of more-conventional measures of morbidity and mortality. McEwen (2004) distinguished an allostatic state (Koob and Le Moal 2001) , refl ecting "chronic imbalance in the regulatory system" (McEwen 2004:67) , from allostatic load, described as the "cumulative changes that refl ect continued operation of the allostatic state" (McEwen 2004:67) . In this framework, "primary mediators" are defi ned as indicators of allostatic states and include a broad array of hormones that mediate the body's response to stressors through their effects on physiological systems (McEwen 2002 (McEwen , 2004 McEwen and Seeman 1999) . Primary mediators include markers of sympathetic nervous system (SNS) activity, hypothalamic-pituitary-adrenal (HPA) axis activity, infl ammation, and growth hormone responses. The accumulation of allostatic load is refl ected in the development of "secondary outcomes" that result from chronic effects of primary mediators (McEwen 2002 (McEwen , 2004 McEwen and Seeman 1999 in Adults 2001), which can be assessed by several risk factors for cardiovascular disease (e.g., blood pressure, sugar, and cholesterol levels; body mass index; and waist-to-hip ratio). Permanent disease states are termed tertiary outcomes (McEwen and Seeman 1999) .
A key tenet of the allostatic load framework is that biological mediators of stressful experience are benefi cial under the balanced interactions that characterize healthy physiological systems. However, chronic stimulation of the mediators induces dysregulation among these systems and results in the accumulation of allostatic load and deleterious health outcomes (McEwen 2004) . In this article, we use recently collected survey data to develop a new approach for measuring the physiological dysregulation associated with allostatic load. The term physiological dysregulation has been used previously (e.g., Crimmins et al. 2003) and is used here instead of allostatic load to distinguish the mechanism through which allostatic load may drive changes in health from the concept of allostatic load itself.
The original, and most frequently used, summary measure of physiological dysregulation (Seeman et al. 1997 ) is calculated as the sum of the number of biomarkers (out of 10) for which an individual falls into the "highest risk" quartile. Two alternative approaches, developed to overcome some of the limitations of the original measure, are more complex. The fi rst uses canonical correlation to determine the linear combination of biological measures that is maximally correlated with declines in functional status (Karlamangla et al. 2002) . The second uses recursive partitioning to classify persons into categories by successively identifying the biological measure (and accompanying cutpoint) that best differentiates among outcomes (Singer, Ryff, and Seeman 2004) . Researchers have demonstrated that these summary measures of dysregulation are associated with diverse health outcomes (e.g., mortality, cognitive and physical function, and cardiovascular disease; Karlamangla et al. 2002; Seeman et al. 1997 ) and various dimensions of the social environment (Schnorpfeil et al. 2003; Seeman et al. 2002) . Recent studies have also provided evidence that both primary mediators and secondary outcomes contribute to the association between the summary measures of dysregulation and health outcomes (Karlamangla et al. 2002; .
Nevertheless, the current summary measures of physiological dysregulation have several limitations. First, the 10-item count and canonical correlation capture risk at only one end of the distribution of each biological measure, despite the possibility that extreme high or low levels of some primary mediators and secondary outcomes are likely to be associated with adverse outcomes (McEwen 2004; Seplaki et al. 2004) . Second, evidence suggests that the levels of the biological values differ between men and women; for example, women may be more likely than men to display elevated levels of primary mediators, while the reverse may be true for secondary outcomes Singer et al. 2004 ). However, approaches that are based on the use of cutpoints of elevated risk (i.e., the 10point measure and recursive partitioning) have not used sex-specifi c values. Third, most of the work to date in this area has been based on the high-functioning sample of older individuals in the MacArthur Study of Aging (Seeman et al. 1997) , leaving open questions of generalizability to broader populations, as well as to non-Western populations. Fourth, with the exception of some recent work that included additional biomarkers relative to the original formulation described earlier (Crimmins et al. 2003; Schnorpfeil et al. 2003) , most summary measures of physiological dysregulation have not incorporated measures of immune function. Last, the formulations based on canonical correlation and recursive partitioning use information on subsequent health outcomes to "optimize" the predictive power of the resulting measure. This approach raises concerns when the measure is derived from and applied to the same data set.
In this analysis, we use data from a national sample of older Taiwanese persons to examine a new approach to the measurement of cumulative physiological dysregulation. We explore its association with fi ve measures of physical and mental functioning that are hypothesized to result from such dysregulation and compare these fi ndings with those based on the commonly used 10-item index. Our formulation differentiates between the potentially distinct roles of primary mediators and secondary outcomes and overcomes many of the limitations described earlier. In particular, it allows for effects at both extremes of the biomarker distributions (when appropriate), incorporates separate cutpoints by sex, avoids using observed outcomes of physical and mental functioning to operationalize the measure, comprises a broad array of biomarkers that includes measures of immune function, and is estimated on a national sample. We also derive the measure under two distinct sets of cutpoints to assess the robustness of our fi ndings.
METHODS

Data
We use data from the 2000 Social Environment and Biomarkers of Aging Study (SEBAS). These data are based on the Taiwan Survey of Health and Living Status, a longitudinal study of a nationally representative probability sample that began in 1989 with persons aged 60 and older, and included follow-ups in 1993, 1996, and 1999 . A new sample of middle-aged persons (age 50 to 66) was added for the 1996 wave. As part of SEBAS, a random subsample of 1,713 persons drawn from both cohorts was selected to be surveyed in 2000; persons older than age 70 in 2000 and those in urban areas were oversampled. This sampling design forms the basis for the two age groups used in this analysis (≤ 70 and > 70) . SEBAS consisted of two parts: an in-home survey (N = 1,497, a 92% response rate among survivors) and a hospital medical exam conducted by a physician (N = 1,023, 68% of those interviewed). Participants in the in-home survey provided data on their health and health history, while those in the medical exam subset also provided fasting blood and 12-hour overnight urine specimens, as well as blood pressure and anthropometric measurements from a physical examination.
Compliance by those who completed the medical exam was extremely high: all but 10 individuals followed the urine protocol, provided a suffi cient volume of blood that was suitable for analysis, and completed the medical exam. A comparison of the characteristics of nonparticipants and participants in the medical exam suggests that in the presence of controls for age, estimates that are derived from clinical information are unlikely to be seriously biased . Specifi cally, although persons older than age 70 were less likely to participate in the medical exam than younger persons, sex and various measures of socioeconomic status were not signifi cantly related to participation. Persons who received the medical exam reported the same average self-assessed health status (on a fi ve-point scale) as those who did not.
Among the 1,023 persons who participated in the medical exam, 10 individuals for whom data were missing on at least one of the biomarkers were excluded from this analysis. In addition, for a small number of individuals, values were missing for at least one of the self-reported functional outcomes. These modifi cations yielded a sample of 972 individuals (571 men and 401 women) for our analysis.
Measures
We use a total of 16 biological measures that represent both primary mediators and secondary outcomes (see Appendix Table A1 ). Comprehensive descriptions of the function of many of these biomarkers in relation to allostatic load are available elsewhere (Brunner 1997; McEwen 2004; Singer et al. 2004) . The primary mediators we examine are epinephrine, norepinephrine, dopamine, cortisol, dehydroepiandrosterone sulfate (DHEA-S), insulin-like growth factor-1 (IGF-1), and interleukin-6 (IL-6). SNS activity is captured by epinephrine and norepinephrine, which help to regulate cardiovascular function and energy stores (e.g., during the "fi ght-or-fl ight" response; Brown 1994) . Dopamine, though not typically included in summary measures of physiological dysregulation, affects memory and motor control (Arnsten 1997; Brown 1994; Seamans and Yang 2004) and can be infl uenced by stress (Fuchs and Flugge 2003) . Cortisol refl ects HPA-axis activity and infl uences carbohydrate metabolism and immune function (Brown 1994) . IL-6, a marker of immune system activity, is positively associated with chronic stress (Kiecolt-Glaser et al. 2003 ) and mortality (Reuben et al. 2002) and may be an indicator of the risk of cardiovascular disease (Jenny et al. 2002; Libby and Ridker 1999; Pai et al. 2004) . IGF-1 is associated with muscle growth (Borst and Lowenthal 1997; Cappola et al. 2001 ) and plays a role in immune function (Clark 1997) . Specifi cally, there is some evidence that lower levels of IGF-1 and higher levels of IL-6 may together be associated with poor outcomes (Cappola et al. 2003; Leng et al. 2004 ). DHEA-S is an antagonist of cortisol (Kalimi et al. 1994) and is positively associated with better health (Berr et al. 1996; Leng et al. 2004; Mazat et al. 2001; Valenti et al. 2004) .
Secondary outcomes comprise average systolic and diastolic blood pressures, total serum cholesterol, the ratio of total to high-density lipoprotein (HDL) cholesterol, triglycerides, fasting glucose and glycosylated hemoglobin (a measure of the percentage of hemoglobin molecules in the blood that are bound to glucose), body mass index (BMI), and waist-to-hip ratio. The blood pressure and cholesterol measures are standard indicators of cardiovascular disease risk, while the fasting glucose and glycosylated hemoglobin measures indicate metabolic function effi ciency (the latter refl ects glucose levels that are integrated over a longer period of time). BMI and waist-to-hip ratio measure body composition and fat distribution, respectively, and refl ect cardiovascular disease risk (Davidson et al. 1999; Seidell and Visscher 2000; Terry, Page, and Haskell 1992) .
Measures are derived from the physical examination and the urine and blood specimens. Twelve-hour urine specimens yielded measures on cortisol, norepinephrine, epinephrine, and dopamine (a 12-hour urine specimen is necessary to obtain integrated measures of these markers because of diurnal variation). Measurements for cortisol, epinephrine, and norepinephrine are reported as "micrograms per gram creatinine" to adjust for body size. The fasting blood specimens yielded assays of HDL cholesterol, total cholesterol, triglycerides, fasting glucose, glycosylated hemoglobin, DHEA-S, IGF-1, and IL-6. Blood pressure and anthropometric measurements collected during the physical examination yielded systolic and diastolic blood pressures (each calculated as the average of two seated blood pressure readings, taken about one minute apart, using a mercury sphygmomanometer). Measures were also taken for height, weight, and hip and waist circumference-the data used to calculate BMI (defi ned as weight in kilograms divided by height in meters squared) and the waist-to-hip ratio.
Blood and urine specimens were sent to Union Clinical Laboratories (UCL) in Taipei for the assays. During the early stages of fi eldwork, nine individuals outside the targeted sample contributed triplicate sets of specimens. Thus, in addition to the routine standardization and calibration tests performed by the laboratory, two sets of these specimens were submitted to UCL, and the third set was sent to Quest Diagnostics in the United States for analysis. The resulting data indicate good inter-and intra-lab reliability, with intraclass correlations of .80 or higher for duplicates sent to UCL and inter-lab correlations of .76 or higher between the results from UCL and Quest Diagnostics.
We divide each biomarker into three categories: low, middle (i.e., moderate), and high. The low and high categories are designed to capture values outside normal operating ranges and the potential for risk at both extremes of each biomarker distribution, as suggested by the allostatic load conceptual framework (McEwen 2004) and supported by analyses that compared different summary measure formulations (Seplaki et al. 2005) . Two exceptions to the assumption of risk at both extremes are DHEA-S (for which only low values are assumed to denote risk; Glei et al. 2004 ) and the total-to-HDL cholesterol (for which only high values are assumed to denote risk; e.g., Wang et al. 2001) . Two distinct sets of cutpoints are used to defi ne the categories: (1) values below the 10th percentile, between the 10th and 90th percentiles, and above the 90th percentile and (2) values below the 25th percentile, between the 25th and 75th percentiles, and above the 75th percentile. The lower cutpoints for epinephrine and IL-6 are below assay sensitivity (BAS) in several instances in Appendix Table A1 ; assay sensitivity for epinephrine is < 2 μg/L, while assay sensitivity for IL-6 is < 0.1 pg/mL. As noted earlier, cutpoints are defi ned separately by sex.
The health outcomes examined in this analysis represent a broad range of physical and mental functioning that refl ects the multisystem dynamics of cumulative physiological dysregulation: (1) self-assessed health (measured on a 5-point scale: 1 = poor, 2 = not so good, 3 = average, 4 = good, and 5 = excellent), (2) an indicator for the presence of at least one impairment of an activity of daily living (ADL), (3) a count of mobility impairments, (4) an index of cognitive performance (a count of correct responses), and (5) a count of depressive symptoms. ADLs comprise bathing; dressing; eating; getting out of bed, standing up, sitting in a chair; moving around the house; and going to the toilet. Mobility limitations comprise diffi culty squatting, climbing 2-3 fl ights of stairs, lifting 11-12 kilograms, doing physical work at home, walking 200-300 meters, standing continuously for 15 minutes, and running a short distance (20-30 meters). Depressive symptoms are measured by a 10-item version of the original 20-item Center for Epidemiologic Studies Depression (CES-D) scale (Radloff 1977) . Previous studies have demonstrated that a shortened form of the CES-D yields similar internal consistency, factor structure, and accuracy in detecting depressive symptoms as the full 20-item CES-D among elderly Chinese (Boey 1999 ) and other populations (Kohout et al. 1993; Shrout and Yager 1989) . Items forming the CES-D index used here (potential range of 0 to 30) include reports (in the past week) of no interest in eating, sleeping poorly, being in a terrible mood, feeling lonely, people not being nice, feeling anguished, having no energy to do things, feeling joyful (reverse coded), that doing anything is exhausting, and that life is going well (reverse coded). The measure of cognitive function (potential range of 0 to 24) includes 12 items that were adapted from three tests: the modifi ed Short Portable Mental Status Questionnaire (Pfeiffer 1975) , the modifi ed Rey Auditory Verbal Learning Test (Lezak 1983) , and a modifi cation of the Digits Backward test (Wechsler 1981) .
Analysis
The analysis has three parts. We fi rst defi ne, a priori, fi ve distinct, idealized profi les of biomarker combinations. We then use a grade of membership (GOM) model (Manton, Woodbury, and Tolley 1994) to estimate fi ve "GOM scores" for each respondent in the sample; the resulting scores measure individuals' similarity to the fi ve profi les. In the second part of the analysis, we use the GOM scores to predict each of the fi ve health outcomes described earlier (in separate regression models). In the third part of the analysis, we calculate a single GOM index from the GOM scores and evaluate it alongside the conventional 10-item index of dysregulation as predictors of the fi ve health outcomes. We perform all three parts of the analysis using both sets of biomarker cutpoints (the 10/90 and 25/75 percentiles). The three parts of the analysis are elaborated next.
GOM is an analytic technique that has been used to describe the complex comorbid physical and mental health status of older populations in terms of (1) a set of K puretype profi les that refl ect potentially complex health states and (2) a set of K GOM scores for each person that measure the person's similarity to each pure-type profi le (Berkman, Singer, and Manton 1989; Manton et al. 1994; Portrait, Lindeboom, and Deeg 2001) . Each pure-type profi le is defi ned by a collection of response probabilities corresponding to every level of each health variable. In our case, the pure-type profi les refl ect combinations of the discrete variables measuring low (or BAS), middle, or high values on each of the 16 biological parameters. Each person's individual GOM scores must be between 0 and 1 and sum to unity.
In contrast to many prior applications of GOM estimation, which iteratively estimate both the characteristics of the pure-type profi les (i.e., the response probabilities) and the scores quantifying each person's similarity to each profi le, we chose in advance of the estimation fi ve pure-type profi les that highlight specifi c forms of physiological dysregulation. The GOM scores were then calculated for each person relative to these fi ve profi les (the profi les were held constant). Additional details on GOM models and GOM estimation are provided elsewhere (Berkman et al. 1989; Manton et al. 1994) . All GOM analyses reported here were performed using the software by Charpentier (1996) .
Four of the fi ve pure-type profi les refl ect four specifi c manifestations of elevated risk for poor health outcomes: low primary mediators, high primary mediators, low secondary outcomes, and high secondary outcomes. By default, moderate (i.e., middle) levels of each biomarker are assumed to refl ect relatively low risk (i.e., "not at risk" levels). Thus, a fi fth "reference" pure-type profi le was defi ned to represent the lowest risk: moderate values of all primary mediators and secondary outcomes. With some simplifi cation (discussed later), the fi ve pure-type profi les denote (1) not-at-risk moderate levels of all biological variables, (2) at-risk low levels of primary mediators (with not-at-risk secondary outcome levels), (3) at-risk high levels of primary mediators (with not-at-risk secondary outcomes), (4) at-risk low levels of secondary outcomes (with not-at-risk primary mediators), and (5) at-risk high levels of secondary outcomes (with not-at-risk primary mediators).
The full characterizations of each pure-type profi le are presented in Table 1 . They are more complex than was indicated by the preceding summary of pure-type profi les because of the single tails of risk assumed for DHEA-S (low values) and the total-to-HDL cholesterol ratio (high values). Each cell entry in Table 1 defi nes one or more levels (low, middle, or high) for each subset of biomarkers (primary mediators and secondary outcomes). Cell entries in boldface denote pure-type profi le characteristics that are hypothesized to be associated with an elevated risk of poor health outcomes. The levels shown in each cell entry (e.g., low, middle, or high) indicate that the profi le is constrained to have a probability of response that equals 1 for that level, for each biomarker in the given biomarker subset. Entries that specify two levels (e.g., low/middle) indicate that the probability of response for the associated profi le is constrained to be divided evenly between those levels (the probability of response = 1/2 for each); these combinations were selected to denote the complement of the single tail of DHEA-S or the ratio of total-to-HDL cholesterol that embodies high risk for poor health. Cell entries that refl ect all levels (low/middle/high) signify that the associated pure-type profi le is constrained to have an equal probability (1/3) of being Descriptions that include two levels (e.g., low/middle) signify that the pure type has a probability of response that is split evenly between those levels (½ for each).
c Descriptions that include all levels (e.g., low/middle/high) signify that the pure type has an equal probability of being associated with the three possible levels (⅓ for each).
associated with each of the three possible levels (i.e., the profi le can be considered neutral with respect to that biomarker).
Pure-type profi le I is characterized by middle-level values for most biological variables, high or middle DHEA-S, and a low or middle ratio of total-to-HDL cholesterol ratio; theoretically, this profi le represents the lowest level of risk of poor health outcomes. Pure-type profi le II is characterized by at-risk low values of the primary mediators, including DHEA-S, and by not-at-risk values for the secondary outcomes (middle-level for most secondary outcomes and a low or middle cholesterol ratio). Alternatively, pure-type profi le III is characterized by at-risk high values for most of the primary mediators, except DHEA-S, and by the same not-at-risk values for the secondary outcomes as profi le II. No particular level of DHEA-S is identifi ed with this profi le. Pure-type profi les IV and V correspond to pure types II and III, respectively, but focus on at-risk values of the secondary outcomes instead of the primary mediators. Pure-type profi le IV combines low values for most secondary outcomes, except the total-to-HDL cholesterol ratio, with not-at-risk values of the primary mediators. Pure-type profi le V pairs high values for all the secondary outcomes, including the total-to-HDL cholesterol ratio, with the same not-at-risk values for the primary mediators as in pure-type profi le IV.
In the next stage of the analysis, the individual GOM scores, along with controls for age and sex, are used to predict each of the fi ve health outcomes in separate regression models. An ordered probit model is used to predict self-rated health and a logit model is used for the probability of an ADL impairment. Ordinary least squares (OLS) is used to predict the count of mobility limitations, CES-D score, and cognitive score. Robust variance estimates (from the Huber-White estimator) are used to correct for the potential effects of heteroskedasticity and the potential clustering of the SEBAS sample by primary sampling unit. Simulated predicted values are calculated from each model to assist in the interpretation of results. For each biomarker, the simulated probabilities are obtained by (1) sequentially assigning all individuals to the fi rst pure-type profi le, followed by the second profi le, and so on, while leaving age and sex at their observed values and (2) in each case averaging the predicted values across individuals. All regression analyses are carried out using Stata 8.2 (StataCorp 2003).
In the fi nal stage of the analysis, four of the fi ve GOM scores (i.e., excluding the score measuring similarity to the low-risk, or reference, pure-type profi le) are summed to create a single GOM-based summary measure. Because the fi ve scores sum to unity, this sum measures dissimilarity to the low-risk profi le. The conventional, 10-item count ( Seeman et al. 1997 ) is calculated as the number of the following 10 biomarkers for which an individual is in the highest risk quartile: cortisol, epinephrine, norepinephrine, DHEA-S, HDL cholesterol, the ratio of total-to-HDL cholesterol, glycosylated hemoglobin, systolic blood pressure, diastolic blood pressure, and the waist-to-hip ratio. The top quartile (i.e., values above the 75th percentile) is defi ned as high risk for most of the biomarkers; two exceptions are DHEA-S and HDL cholesterol, for which the bottom quartile (i.e., values below the 25th percentile) is defi ned as high risk. We compare the performance of the two summary measures of physiological dysregulation-the single GOM score and the 10-item count-by considering each as a predictor in separate regression models.
RESULTS
Overall, the mean age of the analysis sample is 67.7 years (45% are older than age 70), and 41% of the sample is female. This atypical, male-biased sex ratio refl ects the approximately 1 million Nationalist military and civilian supporters who migrated to Taiwan from Mainland China in 1949 (Gates 1981; Tsai 1992) . Table 2 provides descriptive information on the sample by sex. This table demonstrates that although men in the sample have a slightly higher mean age than women, they are also healthier on average. The sex-specifi c cutpoints used to defi ne the risk categories for each biomarker in the GOM measure are given in Appendix Table A1 , as are the overall cutpoints that defi ne the risk categories of the 10-item index. This table reveals the extensive variation in cutpoint values between men and women for many of the biomarkers, underscoring the potential importance of conditioning cutpoints on sex.
GOM Estimation
The distribution of individuals across the various mixes of the fi ve pure-type profi les is presented in Table 3 for both sets of cutpoints using an approach developed by Berkman et al. (1989) . This table quantifi es the heterogeneity in the biological measures by sequentially parsing out individuals with increasingly complex combinations of GOM scores, beginning with those who are primarily described by one profi le, followed by those who are described by two profi les, and so on.
Following Berkman et al. (1989) , individuals are assumed to be effectively described by a single pure-type profi le if any one of their GOM scores equals or exceeds 0.9. The remainder are assumed to refl ect a two-type (or three-or four-type) mix if the respective sum of their GOM scores for a given mix equals or exceeds 0.9. The remaining balance of the sample, by defi nition, refl ects mixes among all fi ve of the pure-type profi les. In the event of ambiguity between two potential classifi cations for a given individual, the person is assigned randomly to one of the two classifi cation groups (this occurred for one individual under the 10th and 90th percentile cutpoints and for six individuals under the 25th and 75th percentile cutpoints).
The results reveal that few individuals can be described by a single pure-type profi le, but that a sizable fraction can be depicted by a combination of two or three pure-type profi les. Extreme values of both primary mediators and secondary outcomes are prominent in these profi les. In light of the fact that the 10/90 cutpoints defi ne only one-fi fth of individuals as being in an extreme category of a given biomarker, in contrast to one-half for the 25/75 cutpoints, it is not surprising that the specifi c mixes differ considerably between these two sets of estimates. In particular, the use of the 10/90 cutpoints, rather than the 25/75 cutpoints, results in a much higher proportion of individuals being described, in part, by the low-risk profi le (profi le I). Results for the 25/75 cutpoints suggest a substantial number of persons who have low or high values of secondary outcomes (i.e., profi le IV or V, but not both), combined with extreme values of primary mediators (i.e., low and/or high values).
Prediction of Health Outcomes and Comparison With the Existing Measure
Results from the regression models are shown in Table 4 . In these models, coeffi cients for GOM scores are relative to the omitted score for pure type I. Because larger values for self- Notes: Th e sample sizes were 571 men and 401 women. As described in the text, individuals are defi ned as a pure type if any one of their GOM scores equals or exceeds 0.9 (analytical approach based on Berkman et al. 1989) . Individuals are defi ned as a two-(or three-or four-) type mix if the respective sum of their GOM scores equals or exceeds 0.9. Th e remaining balance of the sample, by defi nition, refl ects mixes among all fi ve of the pure types. In the event of ambiguity between two potential classifi cations for a given individual, the person is assigned randomly to one of the two classifi cation groups. See Table 1 assessed health and the cognitive function score signify better health, we anticipate negative coeffi cients for GOM scores for these two health outcomes. In contrast, we anticipate positive coeffi cients for GOM scores for the remaining three outcomes: the presence of an ADL impairment, count of mobility limitations, and CES-D score. The coeffi cient for the female variable represents the association between being female and the outcome net of biological factors that are encompassed within the sex-specifi c cutpoints. These results highlight three general fi ndings. First, increasing similarity to pure-type profi les that are characterized by extreme values for primary mediators and secondary outcomes are signifi cantly and independently associated with diverse measures of physical and mental functioning. Second, both tails of the biomarkers matter; that is, GOM scores measuring increasing similarity to pure-type profi les characterized by high and, alternatively, low values are each signifi cantly and independently associated with functioning. (Note that all the results refer to collections of biomarkers, rather than to individual biomarkers; that is, although we cannot determine whether both low and high values of an individual biomarker are related to functioning, we see that increasing similarity to profi les of low and high values of the set of primary mediators-or secondary outcomes-is related to functioning.) And third, different health outcomes appear to be associated with different sets of biomarkers.
A more detailed assessment of the coeffi cients in Table 4 reveals contrasts between the primary mediators and the secondary outcomes. For the secondary outcomes, high biomarker values are more often associated with adverse functioning than are low values. For example, whereas scores representing high values of the secondary outcomes (score V) are signifi cantly associated with every health outcome that is considered, GOM scores refl ecting low values of the secondary outcomes (score IV) are signifi cantly associated with two or three of the fi ve outcomes (depending on the cutpoints). In contrast, signifi cant associations that result from extreme values of the primary mediators (GOM scores II and III) are as likely to result from low as from high values.
The estimates in Table 4 also suggest variation across the fi ve health outcomes. For example, although most of the high-risk profi le scores are signifi cantly related to mobility limitations and to the CES-D score, only the pure-type profi le score refl ecting high secondary outcomes is signifi cantly associated with the cognitive performance score.
The magnitude and pattern of these associations are illustrated by the predicted values in Table 5 . The profi le characterized by high values of secondary outcomes (score V) is generally associated with the poorest health outcomes (with the exception of the CES-D score). Conversely, as hypothesized, profi le I demonstrates the most-favorable outcomes in all cases with the single exception of the cognitive performance score (for the 10/90 cutpoints).
The fi nal set of analyses compares the associations found using the GOM-based measure of physiological dysregulation with those resulting from the conventional 10-item summary measure (see Table 6 ). This comparison is facilitated by aggregating the four at-risk GOM profi le scores (scores II through V) into a single score that represents the dissimilarity of each individual to profi le I. Two versions of the GOM-based summary score are shown: one based on the 10th and 90th percentile cutpoints and a second based on the 25th and 75th percentile cutpoints. The latter operationalization is more comparable to the 10-item count, which uses quartiles to identify the high-risk categories. Three regression models are estimated for each health outcome. Each model includes controls for age and sex, along with a single summary measure (i.e., the 10-item count, the GOM-based score using the 10/90 cutpoints, and the GOM-based score using the 25/75 cutpoints, respectively).
The estimated coeffi cients in Table 6 demonstrate that the 10-item count measure is signifi cantly associated (p < .05) with three of the fi ve outcomes (self-assessed health, mobility limitations, and cognitive score, but not ADL limitations and the CES-D score). The GOM-based score using the 10/90 cutpoints is signifi cantly associated with four of the fi ve outcomes (all except cognitive score), whereas the GOM-based score using the 25/75 cutpoints is signifi cantly associated with all fi ve outcomes. Overall, the R 2 (or pseudo-R 2 ) values suggest that the GOM-based summary measures account for more variation in the outcomes than the 10-item count measure and that the 10/90 variant accounts for more variation than the 25/75 variant. Related analyses (Seplaki et al. 2005) suggest that the improvement of Note: Predicted values are obtained by assigning all individuals to a given GOM profi le (leaving age and sex at their observed values) and averaging the resulting predicted values across individuals. a Signifi cantly diff erent from pure type I (p < .05), as given in Table 4. the GOM-based summary score relative to the conventional 10-item count may result partly from the inclusion of additional biomarkers and partly from the use of two tails of risk. Nevertheless, the R 2 values and the associated increments are generally small.
DISCUSSION
This article contributes to the literature on cumulative physiological dysregulation in three important ways. First, it provides empirical support for the framework of allostatic load described by McEwen and Seeman (1999) and McEwen (2002) . Specifi cally, the results Table 6 . Comparison of Single GOM Score With the 10-Item Summary Measure confi rm the utility of distinguishing between groups of primary mediators and secondary outcomes-scores measuring similarity to respective subsets of biomarkers are each significantly and independently related to different outcomes. The fi ndings also corroborate previous research that demonstrated that measures of cumulative physiological dysregulation may be signifi cantly associated with health outcomes, even though individual biomarkers may not demonstrate signifi cant associations with such outcomes. (See Seplaki et al. 2004 for an analysis of the association between individual biomarkers and health outcomes, based on the SEBAS sample.)
The second contribution of this work is the development of a measure of cumulative physiological dysregulation that embodies several improvements over prior measures. The new measure recognizes both high and low values and incorporates more biomarkers than the conventional measure. As a consequence, the new measure reveals somewhat stronger associations with a broad set of health outcomes that are hypothesized to result from physiological dysregulation. Despite the fact that alternative sets of cutpoints produce very different profi le descriptions of the sample, the associations between the GOM-based measure and the health outcomes are generally robust to the two sets of cutpoints explored here. In addition, because the new measure does not rely on information on "downstream" physical and mental functioning, it is not subject to the endogeneity concerns that characterize some of the other formulations.
The third contribution of this research is the derivation of a measure that encompasses distinct and biologically meaningful components of physiological dysregulation. Although the measure can be represented as a single score, it was developed theoretically as a set of four related scores that quantify the similarity of an individual to different confi gurations of primary mediators and secondary outcomes. Because these profi les refl ect different types and stages of dysregulation, the full set of GOM scores may provide more insights than current formulations into mechanisms that link the social environment with poor health, while still capturing the cumulative aspects of dysregulation across multiple systems.
Last, we provide an analysis of physiological dysregulation that focuses on a representative sample from a non-Western population. This is important for two reasons. First, research has demonstrated that the distributions of the biomarkers may vary across countries. For example, sex differences in the biomarker distributions are smaller in this sample of older Taiwanese persons than in comparable U.S. samples . Such results emphasize the need to gain a better understanding of the behavior of these biomarkers, the summary measures that are created from them, and the interaction among the physiological systems they represent. Second, older Taiwanese persons are likely to embody a unique accumulation of challenging life experiences, given the country's rapid economic and demographic changes and challenges to traditional family support (Cornman et al. 2003) .
There are several limitations of this study. First, these analyses are cross sectional, so inferences cannot be made regarding the direction of the association between the biomarker profi le scores and health outcomes. For example, although it is tempting to suggest that low levels of DHEA-S lead to poor health and a short life span, it is also possible that certain illnesses reduce the levels of DHEA-S (Berr et al. 1996; Yaffe et al. 1998) .
Second, although almost all the fi ndings discussed in this article are robust to the use of the two sets of cutpoints, several of the coeffi cients and associated z statistics are sensitive to the alternative specifi cations. This is especially problematic because the selection of these two sets of cutpoints is largely arbitrary.
Third, because our focus is on exploring a new approach to summarizing complex biological measurements in the context of allostatic load, not on developing comprehensive outcome-prediction models, the estimated prediction models control only for age and sex. Thus, for example, the association between the physiological dysregulation measure and the cognitive score may be confounded by education (e.g., Tombaugh and McIntyre 1992) .
A fourth limitation is that the results presented here focus on associations involving single biological profi les (i.e., the fi ve GOM pure-type profi le scores) rather than the complex mixes among profi les that characterize most individuals (e.g., interactions among the GOM scores). A related point is the extreme simplicity of the GOM pure-type profi les that are used here and the importance of future work to incorporate greater complexity. Our purpose has been to explore an approach to summarizing (in an interpretable way) a complex set of biomarkers and the physiological systems they represent. That is, the pure-type profi les are defi ned to be simple, at the obvious cost of excluding potentially meaningful interactions among biomarkers (e.g., relationships between IGF-1 and IL-6; Cappola et al. 2003; Leng et al. 2004 ). Revisions of the basic profi les that are used in this analysis and identifi cation of key combinations of biological measures that signal elevated risk are important areas for future research.
These drawbacks underscore the need for future research in two domains. One important task is the establishment of systematic criteria for defi ning what is outside a "normal" or "low-risk" range for measurements of biological dysregulation. Clinically defi ned cutpoints do not exist for many of these biomarkers and, in any case, would not be suitable for this endeavor, given the emphasis of allostatic load on providing "early warnings" for future negative health outcomes. As indicated earlier, the other needed area of research is an examination of how more complex combinations of biomarkers are related to health outcomes.
During the past few years, social scientists and epidemiologists have expended considerable effort to design and fi eld population-based surveys that incorporate rich social and biological information, along with longitudinal information on health and survival. The future availability of such data will permit researchers to accomplish the proposed tasks described earlier. These data would also provide additional opportunities to explore improved summary measures of dysregulation, to validate them, and to compare them with existing formulations. Th reshold values for epinephrine and IL-6 are below assay sensitivity (BAS); approximately 33% of the readings on IL-6 and 20% of the readings on epinephrine fell below the sensitivity of the assays (< 2 μg/L for epinephrine and < 0.1 pg/mL for IL-6). c Counts represent the maximum number of observations over which the percentiles for any one of the biomarkers are calculated; the number of missing observations varies across the biomarkers.
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